Smoking History Predicts for Increased Risk of Second Primary Lung Cancer: A Comprehensive Analysis

被引:46
|
作者
Boyle, John M. [1 ]
Tandberg, Daniel J. [1 ]
Chino, Junzo P. [1 ]
D'Amico, Thomas A. [2 ]
Ready, Neal E. [3 ]
Kelsey, Chris R. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Div Cardiothorac Surg, Dept Surg, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Div Med Oncol, Dept Med, Durham, NC 27710 USA
关键词
second primary lung cancer; lung cancer; smoking; survival; smoking cessation; LONG-TERM SURVIVAL; NEVER-SMOKERS; LOCAL RECURRENCE; RESECTION; CESSATION; TUMORS;
D O I
10.1002/cncr.29095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUNDTobacco use is the most important risk factor for the development of lung cancer. The objective of the current study was to determine the effect of smoking on the development of second primary lung cancers (SPLCs) and other clinical outcomes after surgery for non-small cell lung cancer (NSCLC). METHODSAll patients who underwent surgery for NSCLC at the study institution from 1995 through 2008 were identified. Rates of SPLC were analyzed based on smoking status and pack-year exposure. Multivariate analysis was performed to determine risk factors for SPLC. Overall survival, local control, distant metastases, and postoperative mortality were also examined. RESULTSA total of 1484 patients were identified, including 98 never-smokers. The incidence of SPLC at 3 years, 5 years, and 8 years was 5%, 8%, and 16%, respectively. Only 1 never-smoker developed an SPLC. On multivariate analysis, which was restricted to ever-smokers with pack-years as a continuous variable, smoking history was found to be the only independent risk factor for SPLC (hazard ratio, 1.08; 95% confidence interval, 1.02-1.16 [P=.031]), corresponding to an 8% increased risk per 10 pack-year exposure. There were no differences in rates of local control or distant metastases based on smoking status. There was a trend toward lower postoperative mortality in never-smokers compared with ever-smokers (0% vs 3.3%; P=.069). Overall survival was found to be significantly worse for current smokers compared with former and never-smokers. CONCLUSIONSSPLCs are rare in never-smokers. Increasing tobacco exposure is associated with a higher risk of SPLC in patients with a history of smoking. Current smokers have an increased risk of mortality whereas former and never-smokers have comparable survival. Cancer 2015;121:598-604. (c) 2014 American Cancer Society. The current study identifies and quantifies risk factors for second primary lung cancer in a population of patients treated for an index non-small cell lung cancer. Among 1484 subjects, it was found that smoking was the only risk factor assessed that predicted for the development of a second primary lung cancer, with never-smokers having an exceedingly low risk.
引用
收藏
页码:598 / 604
页数:7
相关论文
共 50 条
  • [1] Tobacco Smoking and Risk of Second Primary Lung Cancer
    Aredo, Jacqueline V.
    Luo, Sophia J.
    Gardner, Rebecca M.
    Sanyal, Nilotpal
    Choi, Eunji
    Hickey, Thomas P.
    Riley, Thomas L.
    Huang, Wen-Yi
    Kurian, Allison W.
    Leung, Ann N.
    Wilkens, Lynne R.
    Robbins, Hilary A.
    Riboli, Elio
    Kaaks, Rudolf
    Tjonneland, Anne
    Vermeulen, Roel C. H.
    Panico, Salvatore
    Marchand, Loic Le
    Amos, Christopher I.
    Hung, Rayjean J.
    Freedman, Neal D.
    Johansson, Mattias
    Cheng, Iona
    Wakelee, Heather A.
    Han, Summer S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (06) : 968 - 979
  • [2] Risk Stratification for Second Primary Lung Cancer
    Han, Summer S.
    Rivera, Gabriel A.
    Tammemagi, Martin C.
    Plevritis, Sylvia K.
    Gomez, Scarlett L.
    Cheng, Iona
    Wakelee, Heather A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (25) : 2893 - +
  • [3] Second Primary Lung Cancer - An Emerging Issue in Lung Cancer Survivors
    Jensen, Sarah Ostrup
    Moore, David A.
    Surani, Arif A.
    Crosbie, Philip A. J.
    Rosenfeld, Nitzan
    Rintoul, Robert C.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : 1415 - 1426
  • [4] Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium
    Cote, Michele L.
    Liu, Mei
    Bonassi, Stefano
    Neri, Monica
    Schwartz, Ann G.
    Christiani, David C.
    Spitz, Margaret R.
    Muscat, Joshua E.
    Rennert, Gad
    Aben, Katja K.
    Andrew, Angeline S.
    Bencko, Vladimir
    Bickeboeller, Heike
    Boffetta, Paolo
    Brennan, Paul
    Brenner, Hermann
    Duell, Eric J.
    Fabianova, Eleonora
    Field, John K.
    Foretova, Lenka
    Friis, Soren
    Harris, Curtis C.
    Holcatova, Ivana
    Hong, Yun-Chul
    Isla, Dolores
    Janout, Vladimir
    Kiemeney, Lambertus A.
    Kiyohara, Chikako
    Lan, Qing
    Lazarus, Philip
    Lissowska, Jolanta
    Le Marchand, Loic
    Mates, Dana
    Matsuo, Keitaro
    Mayordomo, Jose I.
    McLaughlin, John R.
    Morgenstern, Hal
    Mueeller, Heiko
    Orlow, Irene
    Park, Bernard J.
    Pinchev, Mila
    Raji, Olaide Y.
    Rennert, Hedy S.
    Rudnai, Peter
    Seow, Adeline
    Stucker, Isabelle
    Szeszenia-Dabrowska, Neonila
    Teare, M. Dawn
    Tjonnelan, Anne
    Ugolini, Donatella
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (13) : 1957 - 1968
  • [5] Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening
    Nofal, Sara
    Niu, Jiangong
    Resong, Paul
    Jin, Jeff
    Merriman, Kelly W.
    Le, Xiuning
    Katki, Hormuzd
    Heymach, John
    Antonoff, Mara B.
    Ostrin, Edwin
    Wu, Jia
    Zhang, Jianjun
    Toumazis, Iakovos
    CANCER MEDICINE, 2024, 13 (05):
  • [6] Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer
    Fisher, Amanda
    Kim, Seongho
    Farhat, Dina
    Belzer, Kimberly
    Milczuk, MaryAnn
    French, Courtney
    Mamdani, Hirva
    Sukari, Ammar
    Baciewicz, Frank
    Schwartz, Ann G.
    Wozniak, Antoinette
    Nagasaka, Misako
    CLINICAL LUNG CANCER, 2021, 22 (06) : E842 - E850
  • [7] The Effects of smoking status and smoking history on patients with brain metastases from lung cancer
    Shenker, Rachel F.
    McTyre, Emory R.
    Ruiz, Jimmy
    Weaver, Kathryn E.
    Cramer, Christina
    Alphonse-Sullivan, Natalie K.
    Farris, Michael
    Petty, William J.
    Bonomi, Marcelo R.
    Watabe, Kounosuke
    Laxton, Adrian W.
    Tatter, Stephen B.
    Warren, Graham W.
    Chan, Michael D.
    CANCER MEDICINE, 2017, 6 (05): : 944 - 952
  • [8] Prognostic value of circulating proteins at diagnosis among patients with lung cancer: a comprehensive analysis by smoking status
    Feng, Xiaoshuang
    Robbins, Hilary A.
    Mukeriya, Anush
    Foretova, Lenka
    Holcatova, Ivana
    Janout, Vladimir
    Lissowska, Jolanta
    Ognjanovic, Miodrag
    Swiatkowska, Beata
    Zaridze, David
    Brennan, Paul
    Johansson, Mattias
    Sheikh, Mahdi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (09) : 2326 - 2339
  • [9] Expediting Comprehensive Molecular Analysis to Optimize Initial Treatment of Lung Cancer Patients With Minimal Smoking History
    Dagogo-Jack, Ibiayi
    Robinson, Hayley
    Mino-Kenudson, Mari
    Farago, Anna F.
    Kamesan, Vashine
    Iafrate, A. John
    Shaw, Alice T.
    Lennerz, Jochen K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) : 835 - 843
  • [10] Does irradiation for initial primary lung cancer affect the risk of metachronous second primary lung cancer?
    Xinyu Song
    Zhigang Hu
    Yufeng Tian
    Yeqing Guo
    Radiation and Environmental Biophysics, 2021, 60 : 475 - 483